Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 5616 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d568-d1a6-7715-b830-8e1542b1c784

adms:identifier	mi-legislature-measure 2023-2024/HB/5616
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	Samantha Steckloff
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-HB-5616 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-HB-5616 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-HB-5616 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-HB-5616
schema:legislationChanges	1978 PA 368
schema:legislationIdentifier	HB 5616
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; allow patients to take unused portion of eye drops or eye ointments after certain procedures for continued patient care; provide for. Amends 1978 PA 368 (MCL 333.1101 - 333.25211 ) by adding secs. 17773, 20817 & 21537.en
schema:sponsor	Alabas Farhat Natalie Price Helena Scott Mike McFall Erin Byrnes Stephanie A Young Samantha Steckloff Kelly A Breen Jason Morgan Brenda Carter Gina Johnsen Carol Glanville Curtis S VanderWall Jaime Churches Felicia Brabec Jim Haadsma Rachel Hood
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-HB-5616
skos:prefLabel	HB 5616 (2023-2024)en
status	in committee
status date	2024-12-18xsd:date